Alamar Biosciences推出NULISAqpcr™阿尔茨海默病五重检测试剂盒,仅需一份血样即可同步定量检测五项核心血液生物标志物,包括BD-pTau217、NfL、Aβ42、GFAP及APOE4基因携带状态,兼具超高灵敏度、特异性与易用性,可精准监测病理变化并判定遗传风险。此外,Alamar宣布完成超5000万美元(约合人民币3.49亿元)超额认购可转换债券融资,由现有及新投资者共同...
Source LinkAlamar Biosciences推出NULISAqpcr™阿尔茨海默病五重检测试剂盒,仅需一份血样即可同步定量检测五项核心血液生物标志物,包括BD-pTau217、NfL、Aβ42、GFAP及APOE4基因携带状态,兼具超高灵敏度、特异性与易用性,可精准监测病理变化并判定遗传风险。此外,Alamar宣布完成超5000万美元(约合人民币3.49亿元)超额认购可转换债券融资,由现有及新投资者共同...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.